Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar® (PVA)
Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar®
Sponsor: Lund University
A PHASE4 clinical study on Rheumatoid Arthritis and Spondylarthropathy, this trial is completed. The trial is conducted by Lund University and has accumulated 9 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Nov 2018 — Jan 2019 [monthly]
Completed PHASE4
Status: Enrolling By Invitation → Completed
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Enrolling By Invitation PHASE4
-
Oct 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE4
Status: Unknown Status → Enrolling By Invitation
-
Feb 2017 — Oct 2017 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Aug 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lund University
- Region Skane
For direct contact, visit the study record on ClinicalTrials.gov .